Neuropsychopharmacology
- Neural complexity EEG biomarkers of rapid and post-rapid ketamine effects in late-life treatment-resistant depression: a randomized control trial3 years ago
- Transdiagnostic evaluation of epigenetic age acceleration and burden of psychiatric disorders3 years ago
- LPA1 receptors in the lateral habenula regulate negative affective states associated with alcohol withdrawal3 years ago
- Robust aversive effects of trace amine-associated receptor 1 activation in mice3 years ago
- Predictors of placebo response in three large clinical trials of the V1a receptor antagonist balovaptan in autism spectrum disorder3 years ago
- The effects of D-Cycloserine on corticospinal excitability after repeated spaced intermittent theta-burst transcranial magnetic stimulation: A randomized controlled trial in healthy individuals3 years ago
- Pharmacogenetic activation of parvalbumin interneurons in the prefrontal cortex rescues cognitive deficits induced by adolescent MK801 administration3 years ago
Journal of Psychopharmacology
- The effect of cannabidiol (CBD) on low-frequency activity and functional connectivity in the brain of adults with and without autism spectrum disorder (ASD)7 years ago
- Endocannabinoid system imbalance in the postmortem prefrontal cortex of subjects with schizophrenia7 years ago
- Frontal haemodynamic responses in depression and the effect of electroconvulsive therapy7 years ago
- The serotonin transporter gene-linked polymorphic region (5-HTTLPR) and the sleep-promoting effects of tryptophan: A randomized placebo-controlled crossover study7 years ago
- Impulsivity moderates the effects of dopamine D2 and mixed D1–D2 antagonists in individuals with gambling disorder7 years ago
- Effects of MDMA on neuroplasticity, amyloid burden and phospho-tau expression in APPswe/PS1dE9 mice7 years ago
- Orbitofrontal cortex volume prospectively predicts cannabis and other substance use onset in adolescents7 years ago
European Neuropsychopharmacology
- P.810Real-world effectiveness of mood stabilizer use in persons with schizophrenia6 years ago
- P.768 Quality of life of patients with Parkinson’s disease6 years ago
- P.866Epigenetic control of the glucocorticoid target gene Fkbp5 after stress in the hippocampus6 years ago
- P.778 Electrophysiological indices and expressive deficit domain of negative symptoms in subjects with schizophrenia6 years ago
- P.812Treatment adherence and motivation in psychopharmacological perspective6 years ago
- P.757 Antidepressant treatment decreases IL-6, IL-10 and serum cortisol in major depressive disorder: a meta-analysis of randomized controlled trials6 years ago
- P.867Effects of etifoxine on general but not stress related expression of the translocator protein 18kDa (TSPO) in healthy subjects6 years ago